CD8+T cell responsiveness to anti-PD-1 is epigenetically regulated by Suv39h1 in melanomas (vol 13, 3739, 2022)

被引:0
|
作者
Niborski, Leticia Laura [1 ,2 ,3 ]
Gueguen, Paul [1 ,2 ]
Ye, Mengliang [1 ,2 ]
Thiolat, Allan [4 ,5 ]
Ramos, Rodrigo Nalio [1 ,2 ,3 ]
Caudana, Pamela [1 ,2 ,3 ]
Denizeau, Jordan [1 ,2 ,3 ]
Colombeau, Ludovic [6 ]
Rodriguez, Raphael [6 ]
Goudot, Christel [1 ,2 ]
Luccarini, Jean-Michel [7 ]
Soude, Anne [7 ]
Bournique, Bruno [7 ]
Broqua, Pierre [7 ]
Pace, Luigia [1 ,2 ]
Baulande, Sylvain [8 ]
Sedlik, Christine [1 ,2 ,3 ]
Quivy, Jean-Pierre [1 ,9 ,10 ]
Almouzni, Genevieve [1 ,9 ,10 ]
Cohen, Jose L. [4 ,5 ]
Zueva, Elina [1 ,2 ]
Waterfall, Joshua J. [1 ,3 ,11 ]
Amigorena, Sebastian [1 ,2 ]
Piaggio, Eliane [1 ,2 ,3 ]
机构
[1] PSL Res Univ, Inst Curie, F-75005 Paris, France
[2] INSERM U932, F-75005 Paris, France
[3] Inst Curie, Translat Res Dept, F-75005 Paris, France
[4] Univ Paris Est Creteil Val Marne, Univ Paris Est, UMR S955, Creteil, France
[5] INSERM, Equipe 21, U955, Creteil, France
[6] PSL Res Univ, CNRS UMR3666, Inst Curie, INSERM UMR3666,Chem Biol Canc,Equipe Labellisee L, Paris, France
[7] Inventiva, 50 Rue Dijon, F-21121 Daix, France
[8] Inst Curie Res Ctr, Inst Curie Genom Excellence ICGex Platform, Paris, France
[9] PSL Res Univ, CNRS, Inst Curie, Equipe Labellisee Ligue Canc,UMR3664, Paris, France
[10] Sorbonne Univ, UPMC Univ Paris 06, CNRS, UMR3664, F-7005 Paris, France
[11] INSERM U830, F-75005 Paris, France
关键词
D O I
10.1038/s41467-023-38931-6
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Assessing CD8+cytotoxic T-cell dysfunction in obesity and its implications in anti-PD-1 blockade therapy
    Baracho, Gisele Vanessa
    Song, Hye-Wong
    Taylor, Ian
    Mortimer, Stefanie
    Widmann, Stephanie
    Tyznik, Aaron J.
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [42] Responsiveness of HBV-specific CD8+T cells to PD1 pathway blockade is linked to TCF1 expression
    Schuch, A.
    Wieland, D.
    Hofmann, M.
    Thimme, R.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S30 - S30
  • [43] Anti-PD-1/PD-L1 Based Combination Immunotherapy to Boost Antigen-Specific CD8+ T Cell Response in Hepatocellular Carcinoma
    Pena-Asensio, Julia
    Calvo, Henar
    Torralba, Miguel
    Miquel, Joaquin
    Sanz-de-Villalobos, Eduardo
    Larrubia, Juan-Ramon
    CANCERS, 2021, 13 (08)
  • [44] PD-1 Status in CD8+ T Cells Associates with Survival and Anti-PD-1 Therapeutic Outcomes in Head and Neck Cancer
    Kansy, Benjamin A.
    Concha-Benavente, Fernando
    Srivastava, Raghvendra M.
    Jie, Hyun-Bae
    Shayan, Gulidanna
    Lei, Yu
    Moskovitz, Jessica
    Moy, Jennifer
    Li, Jing
    Brandau, Sven
    Lang, Stephan
    Schmitt, Nicole C.
    Freeman, Gordon J.
    Gooding, William E.
    Clump, David A.
    Ferris, Robert L.
    CANCER RESEARCH, 2017, 77 (22) : 6353 - 6364
  • [45] Clinical significance of CD4+T cell subsets in peripheral blood for anti-PD-1/PD-L1 therapy
    Haruna, Y.
    ANNALS OF ONCOLOGY, 2024, 35 : S274 - S274
  • [46] Monitoring peripheral blood PD-1+CD8+T cells to predict response to anti-PD-1 therapy in solid tumors.
    Kim, Kyung Hwan
    Cho, Jinhyun
    Ku, Bo Mi
    Koh, Jiae
    Sun, Jong-Mu
    Lee, Se-Hoon
    Ahn, Jin Seok
    Park, Su-Hyung
    Park, Keunchil
    Ahn, Myung-Ju
    Shin, Eui-Cheol
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [47] Multifunctionality of CD8+ T cells and PD-L1 expression as a biomarker of anti-PD-1 antibody efficacy in advanced melanoma
    Manabe, Keiko
    Yamasaki, Osamu
    Nakagawa, Yuki
    Miyake, Tomoko
    Udono, Heiichiro
    Morizane, Shin
    JOURNAL OF DERMATOLOGY, 2021, 48 (08): : 1186 - 1192
  • [48] Increased CD3+T cells with a low FOXP3+/CD8+T cell ratio can predict anti-PD-1 therapeutic response in non-small cell lung cancer patients
    Kim, Hyojin
    Kwon, Hyun Jung
    Han, Yeon Bi
    Park, Soo Young
    Kim, Eun Sun
    Kim, Se Hyun
    Kim, Yu Jung
    Lee, Jong Seok
    Chung, Jin-Haeng
    MODERN PATHOLOGY, 2019, 32 (03) : 367 - 375
  • [49] Role of CD4/CD8 double positive T cells in modulating response to anti-PD-1 treatment in renal cell carcinoma
    Sankaran, Satish
    Jaganathan, Kowshik
    Das, Biswajit
    Syamkumar, V
    Bhowal, Chandan
    Mouniss, M.
    Dharanidharan, M.
    Nath, Moumita
    Rajashekar, M.
    Oliyarasi, M.
    Malhotra, Ritu
    Govindaraj, K.
    Malhotra, Mohit
    Basak, Nandini Pal
    CANCER RESEARCH, 2024, 84 (06)
  • [50] CD8+T cells and CD4+central memory T cells as biomarkers of perioperative anti-PD-1 therapy in combination with concurrent chemoradiotherapy for locally advanced G/GEJ adenocarcinoma
    Wang, Yue
    Chen, Yawei
    Yang, Ju
    Zhou, Xiaoyu
    Wei, Yutao
    Liu, Qin
    Yang, Yang
    Guan, Wenxian
    Liu, Baorui
    Wei, Jia
    CANCER RESEARCH, 2024, 84 (06)